Viewing Study NCT04008706


Ignite Creation Date: 2025-12-26 @ 1:17 PM
Ignite Modification Date: 2025-12-31 @ 8:37 PM
Study NCT ID: NCT04008706
Status: COMPLETED
Last Update Posted: 2025-12-01
First Post: 2019-06-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Acalabrutinib Safety Study in Untreated and Relapsed or Refractory Chronic Lymphocytic Leukemia Patients
Sponsor: AstraZeneca
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module